lectures 22-33 Flashcards
centrosome
centrioles and microtubules
interphase G2
2 centrosomes visible (but higher plants and most fungi lack centrioles)
nucleus intact and chromosomes not visible by light microscopy (only visible by FISH)
active
relaxed chromatin: transcription factors can access genes so protein production
FISH (fluorescent in situ hydridisation)
cells fixed and permeabilised with detergent to form monolayer
incubated with fluorescent oligonucleotide primers specific for individual chromosomes
primers hybridise with targets, bind to target by base pairing
chromosomes become painted
prophase
early: centrosomes move to poles
chromosomes condense to visible threads
nuclear membrane disintegrates into small vesicles
nucleus surrounded by microtubules
late: each chromosome composed of 2 sister chromatids held together at centromeres
microtubular spindle fibres grow near centrosomes, some extend across poles, others attach to chromatids at kinetochores
metaphase
chromosomes align in middle between poles
sister chromatids remain attached by centromeres
anaphase
sister chromatids separate into separate independent chromosomes, centromere splits
each centromere attached to spindle fibre and moves to poles
cell elongates and spindle elongates
cytokinesis starts
telophase
chromosomes uncoil and become less distinct
nuclear membranes form around daughter nuclei
nucleoli reform
spindle fibres depolymerise: becomes less distinct and disappears
cytokineses complete: separates 2 daughter cells
interphase G1
after cytokinesis
chromatids in daughter cell double up to give chromosomes in S phase
amount of DNA different to G2
cell cycle
M
G1 - 1st gap, repair damage, growth, duplication
S (synthesis) - chromosomes doubled also centrioles and other organelles doubled
G2 - 2nd gap, ready for mitosis, proteins that condense chromosomes
controller goes round clockwise
experiment for identifying proteins involved in cell division
stimulate egg into growth but not division
fertilised = growth and division
compare proteins between resting, growth, growth and division
spot proteins involved in division (cell cycle controllers)
add radiolabelled methionine at time 0, sample between 25-127 min, place on gel
apply current so separate in size
boil eggs (in presence of SDS negatively charged detergent to keep protein soluble, and reducing agent)
unfertilised (resting): protein X,Y,Z drug stimulation (growth): A,B,C proteins fertilised (growth and division): A accumulates then levels fall and rise again and fall, so named cyclin because cycles with cell cycle, characteristic of dividing
Cyclin A….
expression rises and falls in expression levels after fertilisation (dividing cells)
destroyed every time cell divides
peaks just before cell division
controller, high concentrations stimulate mitosis
where was the cyclin controller first identified?
fertilised sea urchin eggs
cyclin levels of complexity
regulatory, makes decisions of what to phosphorylate and then kinase (CDK) phosphorylates
inactive unless have partner (CDK)
additional layers include cyclin/CDK inhibitors and activators, plus their regulation
cyclin/CDK complexes controlled by destructive phases that reduce their conc after performed function (regularly destroyed)
kinase
phosphorylates
transfer phosphate group
CDK
cyclin dependent kinase
cyclin + CDK process
CDK + cyclin in inactive heterodimeric complex that is prepared to be activated
modifying enzyme makes complex prepared for activity
then complex either activated or inhibitedby CDK inhibitor/activator
if activated, targets chosen by cyclin are phosphorylated by CDK
then complex is destroyed by proteolysis in proteasome (cytosolic proteolytic complex)
G1 cyclin-CDK complexes
3 different CDKs and 2 cyclins, so multiple complexes
prepare cell for S phase
target range of proteins that allow progress through G1 and prepare for S
stimulate and promote expression of S phase cyclin complexes
S phase complexes
only 1 cyclin and CDK as 1 complex
phosphorylates targets which control chromosome replication
conc of S phase controller rises and progress through S phase, then destruction and replaced by G2 complexes
G2 complexes
prepare for mitosis and modify and active spindle fibre formation
controllers in the cell cycle?
G1
S
G2/M
cyclins+CDK
simplest organism has….
2 cyclins
experiment to find out evolution of cyclin+CDK
add flexible linker (Gly4, Ser) between 1 cyclin and 1 CDK
conc. of cyclin and CDK is artificially high so drives them to heterodimerise (join)
Cdc13 (CDK) used because does most work in Sz.pombe
the artificial complex was expressed in Sz.pombe and all others were deleted
cells grew slightly slower but still worked
low conc of the complex phosphorylated G1 targets allowing entry to S phase (high affinity targets, for CDK)
high conc of complex phosphorylates G2/M targets stimulating mitosis (low affinity targets)
so can run with 1 CDK and 1 cylcin
therefore: evolved to form new combinations that performed at diff stages of cell cycle resulting in complexity we see in modern organisms
stationary phase regulation of cell cycle
leave cell cycle and enter quiescent phase
cells stop dividing but if not left too long, can re enter cell cycle if diluted into fresh growth medium
regulated to either leave or enter cell cycle
unicellular cells……. than our cells because…
response better to an env. stimulus
can move away from a bad env but we can’t so our cell cycles are highly regulated
G0 and cancer
cancer cells can enter G0 phase and return to cell cycle, so if kill all rapidly growing cancer cells, may be some cells left in G0 that can’t be targeted and tumour may reform later on - relapse
Radiotherapy targets rapidly growing cells and chemotherapy targets in S phase
cancer cells go quickly through G1 so can’t repair in G1
G0 differentiation and proliferation
cells can differentiate in G0
some differentiated cells remain post-mitotic and don’t re-enter cell cycle
other differentiated can be stimulated by mitogenic signals to re-enter cell cycle and replicate (fibroblasts, lymphocytes)
restriction point: cell is committed to cell cycle and can’t go back (but can return to G0 before this point)
mitogenic signals
EGF ligand (epidermal growth factor) binds to EGFR (EGF transmembrane receptor) dimerises the receptor - 2 kinase domains phosphorylate each other - P is negative so alters the size and charge and contrains flexibility activation
activated EGFR bound by adaptor molecule that recruits and activates cytosolic membrane-bound Ras enzyme (bound to membrane by lipid anchor)
signal transduced from extracellular to intracellular
Ras recruits Raf (kinase so phosphorylates) to membrane and signal passed via intermediates to MAPK (so activated)
signal transduced across cytosol
activated MAPK translocates to nucleus, stimulates expression of early response genes c-FOS and c-JUN
so MAPK acts as transcription factor
c-Fos and c-Jun are transcription factors that induce expression of delayed response genes including cyclins and their partner CDKs
so triggers re-entry to G1 in cell cycle
mitogenesis - induction of mitosis
mitogenic signals: main points
activation of growth factor receptors recruitment of Ras signal transduction (Raf to MAPK) induction of early response genes induction of delayed response genes expression of G1 cyclins and CDKs that return a G0 cell to G1
MAPK
mapkinase
shutting the mitogenic signal off
inappropriate growth signals cause unchecked proliferation (have to shut down or=cancer)
signal cut off by lysosomal targeting and destruction of activated growth factor receptors (EGFR)
Ras cannot be recruited and so on, so shuts down expression of genes
mutational activation of receptors
25% of breast cancers have a mutation in the transmembrane domain of c-erbB1 growth factor receptor
self-activating, dimerising and auto-phosphorylating in absence of growth factor
so causes unregulated proliferation
so has ligand independent manner and forced to divide
mutational activation of Ras
15-30% of all cancers have mutated Ras that permanently activated
so MAPK stimulated in absence of growth factor causing unregulated proliferation
so no need for ligand
mutational activation of Raf
66% of malignant melanomas have mutated BRAF gene that produces permanently activated Raf
so MAPK activated
viral subversion
viral oncogenes products v-JUN and v-FOS mimic action of c-Jun and c-Fos
what might cause genome instability?
deregulation of the cell cycle, running at full speed so no time to proof-read newly replicated DNA before daughter cells are separated
failure of check point means mutations carried to next generation
cell cycle brakes operate in……..
and…..
G1 - repair
G2 - some recognise misincorporation of nucleotides
repair is operated by…
2 proteins
Rb and p53
which slow down the cell cycle so allow repair
childhood retinoblastoma treatment
laser surgery/cryotherapy - small tumours
radiotherapy - local or larger tumours
chemotherapy - tumour spread beyond the eye
surgical removal - if above fail
childhood retinoblastoma hereditary
sporadic
normal Rb+ allele from 1 parent and defective from other
somatic mutation inactivates normal allele so Rb- cell
2 normal Rb+ alleles
2 separate mutations required to inactivate each
rare
Rb
tumour-suppressor gene
stops cells proliferating uncontrollably
inhibits formation of retinoblastoma
Rb protein regulates restriction point (only exists because of Rb)
inhibits G1 controllers so extends time of G1 so more time to check damage (keeps cyclin+CDK complex inactive)
there is a fixed amount of Rb in cells but G1 controllers always manufactured so there’s excess of controllers at restriction point, enough to push into S phase (cyclin+CDK override Rb control)
p53
tumour suppressor
stops genome instability
TP53 mutations associated with 50% of cancer
normally inactive because degraded by proteosome so conc. normaly low
DNA damage makes it stable so activates it (acts as transcription factor)
activates gene expression of proteins that inhibit cyclin/CDK complexes
stops cycle (arrest) or apoptosis
mostly in G1, sometimes G2
works upstream of G0
viral subversion of Rb and p53 human papillomaviruses
E6 protein inhibits p53 so not able to apoptosis
E7 protein inhibits Rb because take restriction point away so no time to check damage
apoptosis process
signal received
mild convolution, chromatin compaction, cytoplasmic condensation
nuclear fragmentation, cell blebbing, cell fragmentation
phagocytosis
no inflammation because no release of cytoplasm
necrosis
die through tissue damage
dying cells swell and burst so inflammation
intracellular constituents released into extracellular matrix
what model organism was used to understand apoptosis?
C. elegans
classes of protein function in C.elegans apoptotic pathways
cells that die by apoptosis would have become neurones mostly
ced-3 mutation : all cells survive, no apoptosis
so some proteins required for cell death, wild type promotes apoptosis
ced-9 mutation: all cells die, so protein suppresses apoptosis
so some proteins required for cell survival
Caspases
effectors for apoptosis
cleaves proteins of the nuclear lamina and cytoskeleton, leading to cell death
cleaves targets at site just C-terminal to aspartic acid residues
normally kept inactive by trophic signals from neighbouring cells
process of suppressing apoptosis
trophic signal from neighbouring cells binds to receptor
keeps procaspase inactive
process of activating apoptosis
no trophic signal
so active caspase
substrate cleavage and cell death
triggers for apoptosis
external: lack of trophic signals (stop telling cells to live)
recognition of stress, virally-infected cells
internal: recognition of irrepairable DNA damage
developmental: remove webbing between fingers, foetal development, remove neurones, highly regulated
the ……… is so high in a cell that………….
even the cytosol is…..
conc. of proteins
it’s close to the limit of solubility
packed and so gel like and not a liquid
cytosol
aqueous component of the cytoplasm (fluid phase)p
site of protein synthesis and metabolic pathways
peroxisome
sites for oxidative reactions
vacuoles
turgor or protein storage/degradation
we can visualise subcellular organelles…….
in vivo using dyes or Fluroscent Proteins such as GFP
how do proteins know where to go?
sorting signals that are part of the protein
can be:
short peptides at N- or C- termini (removed after use or kept for use again)
3-dimensional domains
other molecules attached to protein that not part of sequence itself so post-translational modifications (sugars/lipids)
what happens to sorting signals?
recognised by specific receptors which trigger transfer of protein to correct destination
every organelle uses different receptors and sorting processes because different signals
modes of protein transport
gated transport: physical barrier/gate e.g. nucleus
transmembrane transport: need channels to cross mitochondrial/ER membrane
vesicular transport: surrounded, packaged, fuse
gated transport into the nucleus
large aqueous nuclear pore complexes (NPC)
storage of chromatin, large volue in and out nucleus
transcription factors in and out
pores very abundant
structure of a nuclear pore complex
proteins line ring
rod-shaped proteins - linear and flexible
cytoplasmic ring with cytoplasmic filaments
nuclear basket in nucleoplasm
central transporter in between proximal filaments
massive
made up of many copies of different nucleoporins (proteins)
FG-nucleoporins line the channel, nuclear basket and cytosolic fibrils (F and G AA residues, don’t acquire 2ndary structure but stay in filament)
what sized molecules can rapidly diffuse between cytoplasm and nucleoplasm?
which diffuse slowly?
which can’t enter?
small molecules 5kDa or less
proteins 20-40,000 Da
proteins >40 kDa, RNA, ribosomes
diffusion barrier
unstructured regions of NPC proteins forming tangled network and blocking passive diffusion of large molecules
filaments oscillate and collide so repel materials trying to get in
NLS
nuclear localisation signals
rich in lysine and proline in any position on protein as long as exposed to surface
importins
NLS receptors
cytosolic nuclear import receptors
each responsible for set of cargo molecules
nuclear import
importin binds NLS on cargo protein and binds FG repeats in FG-nucleoporins of fibrils and channel filaments in nuclear pore
transient interations with FG anchor points
repeated binding and dissociation so climb along pore
importin receptors then disengage from cargo in nucleus
NLS not cleaved off
Ran-GDP
Ran-GTP
in cytosol
in nucleus
importin letting go of cargo
Ran binds to importin - triggers conformational change
release protein that was in importin
importin still bound to Ran GTP
importin to cytoplasm, GTP hydrolysed to GDP
so lets go of importin
why is there asymmetric distribution of Ran-GTP and GDP?
because of proteins that can switch Ran on or off
Ran-specific GEF - in nucleus, guanine nucleotide exchange factor (exchanges GDP with GTP, so makes GTP), tightly bound to chromatin in nucleoplasm
Ran-specific GAP - in cytosol, GTPase activating protein (promotes hydrolysis of GTP to GDP), bound to importin
ER functin
lipid synthesis e.g. in adipose tissue
protein translocation - start journey in ER, through translocation pore, proteins acquire native structure in lumen, proteins N-glycosylated (sugar attached to asparagine residue), proteins degraded if fail to assemble
How do proteins enter the ER and secretory pathway?
secretory proteins carry N-terminal signal sequence that targets them to ER (while protein still being made)
co-translational: occurs during translation, recruits receptors that take ribosome with chain to ER
leads to docking of ribosome-nascent chain complex into ER membrane
signal sequence removed once protein in ER so it’s 1-directional
Golgi function
protein and lipid modification (glycan processing, tyrosine sulfation)
protein packaging and sorting (to outside/plasma membrane/lysosomes)
modifies AA residues, decision on where protein go and sorted to diff secretory vesicles
the lumen on the secretory pathway is….
topologically equivalent to the outside of the cell so connected and organelles interconnected
once in the ER, protein doesn’t need to cross any membranes to be secreted
endosome?
vesicle
late endosome become lysosomes
sorting in biosynthetic secretory pathway
proteins for plasma membrane secretion don’t need signal because this is default
proteins for intracellular destinations (lysosomes) need sorting signal
lysosomes
intracellular endpoint of secretory pathway
degrade particles/organisms/proteins/organelles
rich in hydrolytic enzymes
low pH
targeting hydrolytic enzymes to lysosomes
all lysosomal enzymes are glycoproteins (have sugar-glycan)
mannose residues on glycans are modified to mannose 6-phosphate (M6P) - targeting signal
M6P receptors in trans Golgi network (TGN) membrane
binding triggers process that recruits proteins (specific adaptor proteins (AP) and clathrin) that bend Golgi membrane into bud
dynamin protein wrings the neck and structure gets smaller till pinches off vesicle (GTP hydrolysis)
loses clathrin/AP coat and directed to late endosome
M6P receptor off M6P containing protein (from pH)
receptors back to Golgi (vesicle by retromer not clathrin)
clathrin
force membrane to bend
cage contains spherical membrane
what allows lysosomal enzymes to have M6P signal?
have 2nd (3 dimensional) targeting signal that recognised by enzyme in early Golgi, tells to attach phosphate at position 6
has signal patch, recognised by GlcNAc phosphotransferase in early Golgi
binds sugar (UDP-GlcNAc) which carries phosphate
bind phosphate to position 6 on mannose
2nd enzyme (phosphodiesterase removies GlcNAc leaving phosphate bound to mannose residue
lysosomal storage diseases
Gaucher’s disease - lack of glucocerebrosidase which breaks down glucocerebroside
pleiotropic phenotype
treat by giving enzyme
I (inclusion) cell disease (mucolipidosis II) - multiple lysosomal enzymes missing because no GlcNAc phosphotransferase so undigested material, growth ceases
Tay Sachs disease - lysosomal accumulations of gangliosides in neurones (limp baby)
Hunter and Hurler disease - similar to I disease
extracellular matrix (ECM)
major product of secretory pathway
material that surrounds animal cells
produces variety of structures e.g. bone, teeth, tendons,exoskeleton
can also regulate behaviour of resident cells
dynamic
makes tissue function
influences survival, development, migration, shape, proliferation, function of cells